OBJECTIVE: To evaluate the possible impact of a neutral third party on the patients' responses to health-related quality of life (HRQL) instruments. METHODS:119 patients operated at the Department of Urology in Lund withradical cystectomy and continent urinary tract reconstruction (continent cutaneous diversion or orthotopic bladder substitution) for locally advanced bladder cancer were included in the study. They were randomly divided in two groups, similar with regard to gender, age, length of follow-up, and type of reconstruction. The EORTC instruments QLQ-C30 and QLQ-BLM30 were sent to the patients. One group; "Lund patients", received the instruments from the Department of Urology in Lund, while the other group; "Stockholm patients", received the instruments from a neutral third party, i.e. "The Project Health and Well-Being" at the Karolinska Institutet in Stockholm. RESULTS:Response rates were high in both groups, 59 out of 60 among Lund patients and 57 out of 59 among Stockholm patients. There were statistically significantly more bowel problems reported in the Stockholm patients than in the Lund patients (p<0.05) in the QLQ-C30 instrument. Regarding type of reconstruction, the Stockholm patients with continent cutaneous diversion scored higher for constipation than the Lund patients (p<0.05), and the Stockholm patients with bladder substitution scored lower for emotional functioning and higher for dyspnoea and economical problems than the Lund patients (p<0.05. There were no statistically significant differences between the Lund patients and the Stockholm patients in the QLQ-BLM30 instrument. CONCLUSION: Though few factors differed between the two groups, the results may indicate that different results are obtained when a study is totally administered and analyzed by a neutral third party as compared with the surgeon or his or her institution. Larger studies are needed to further test this hypothesis.
RCT Entities:
OBJECTIVE: To evaluate the possible impact of a neutral third party on the patients' responses to health-related quality of life (HRQL) instruments. METHODS: 119 patients operated at the Department of Urology in Lund with radical cystectomy and continent urinary tract reconstruction (continent cutaneous diversion or orthotopic bladder substitution) for locally advanced bladder cancer were included in the study. They were randomly divided in two groups, similar with regard to gender, age, length of follow-up, and type of reconstruction. The EORTC instruments QLQ-C30 and QLQ-BLM30 were sent to the patients. One group; "Lund patients", received the instruments from the Department of Urology in Lund, while the other group; "Stockholm patients", received the instruments from a neutral third party, i.e. "The Project Health and Well-Being" at the Karolinska Institutet in Stockholm. RESULTS: Response rates were high in both groups, 59 out of 60 among Lund patients and 57 out of 59 among Stockholm patients. There were statistically significantly more bowel problems reported in the Stockholm patients than in the Lund patients (p<0.05) in the QLQ-C30 instrument. Regarding type of reconstruction, the Stockholm patients with continent cutaneous diversion scored higher for constipation than the Lund patients (p<0.05), and the Stockholm patients with bladder substitution scored lower for emotional functioning and higher for dyspnoea and economical problems than the Lund patients (p<0.05. There were no statistically significant differences between the Lund patients and the Stockholm patients in the QLQ-BLM30 instrument. CONCLUSION: Though few factors differed between the two groups, the results may indicate that different results are obtained when a study is totally administered and analyzed by a neutral third party as compared with the surgeon or his or her institution. Larger studies are needed to further test this hypothesis.
Authors: Thordis K Thorsteinsdottir; Heiddis Valdimarsdottir; Johan Stranne; Ulrica Wilderäng; Eva Haglind; Gunnar Steineck Journal: Support Care Cancer Date: 2017-12-09 Impact factor: 3.603
Authors: Christopher B Anderson; Bruce Rapkin; Brieyona C Reaves; Arony J Sun; Bradley Morganstern; Guido Dalbagni; Machele Donat; Harry W Herr; Vincent P Laudone; Bernard H Bochner Journal: Psychooncology Date: 2015-11-30 Impact factor: 3.894
Authors: June D Cody; Ghulam Nabi; Norman Dublin; Samuel McClinton; David E Neal; Robert Pickard; Sze M Yong Journal: Cochrane Database Syst Rev Date: 2012-02-15
Authors: David Bock; Martin Nyberg; Anna Lantz; Sigrid V Carlsson; Daniel D Sjoberg; Stefan Carlsson; Johan Stranne; Gunnar Steineck; Peter Wiklund; Eva Haglind; Anders Bjartell Journal: Scand J Urol Date: 2022-05-12 Impact factor: 1.899
Authors: Barbara Erber; Mark Schrader; Kurt Miller; Martin Schostak; Daniel Baumunk; Anja Lingnau; Andres Jan Schrader; Florian Jentzmik Journal: ISRN Urol Date: 2012-02-06